» Articles » PMID: 2549977

Uptake, Production and Metabolism of Cysteinyl Leukotrienes in the Isolated Perfused Rat Liver. Inhibition of Leukotriene Uptake by Cyclosporine

Overview
Journal Biochem J
Specialty Biochemistry
Date 1989 Jul 15
PMID 2549977
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

1. The isolated perfused rat liver efficiently takes up cysteinyl leukotrienes (LTs) C4, D4, E4 and N-acetyl-LTE4 from circulation. More than 70% of these cysteinyl LTs are excreted from liver into bile within 1 h of onset of a 5 min infusion, while about 5% remain in the liver. About 20% of infused N-acetyl-LTE4 escapes hepatic first-pass extraction under our conditions. 2. Metabolites of LTC4 appearing in bile within 20 min of the onset of infusion include mainly LTD4 and N-acetyl-LTE4, but also omega-hydroxy-N-acetyl-LTE4 and omega-carboxy-N-acetyl-LTE4. Metabolites generated from omega-carboxy-N-acetyl-LTE4 by beta-oxidation from the omega-end represent the major biliary LTs secreted at later times. 3. Stimulation of the isolated perfused liver by the combined infusion of the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) and the Ca2+ ionophore A23187 results in a transient increase of endogenous cysteinyl LT production, which is independent of extrahepatic cells. 4. The immunosuppressive drug cyclosporine causes a dose-dependent inhibition of hepatobiliary cysteinyl LT excretion, probably by interference with the sinusoidal uptake system for cysteinyl LTs.

Citing Articles

Investigation of MDMA Inhibitory Effect on CytochromeP450 3A4 in Isolated Perfused Rat Liver Model Using Tramadol.

Sheikholeslami B, Tootoonchi Z, Lavasani H, Ardakani Y, Rouini M Adv Pharm Bull. 2021; 11(3):530-536.

PMID: 34513628 PMC: 8421619. DOI: 10.34172/apb.2021.061.


Hepatobiliary excretion of cysteinyl leukotrienes in three experimental models of acute hepatic injury.

Omar H, Sanders R, Watkins 3rd J Inflamm Res. 1996; 45(10):519-23.

PMID: 8912018 DOI: 10.1007/BF02311089.


Cell proliferation status, cytokine action and protein tyrosine phosphorylation modulate leukotriene biosynthesis in a basophil leukaemia and a mastocytoma cell line.

Hagmann W Biochem J. 1994; 299 ( Pt 2):467-72.

PMID: 7513514 PMC: 1138295. DOI: 10.1042/bj2990467.


Hepatic uptake and metabolic disposition of leukotriene B4 in rats.

Hagmann W, Korte M Biochem J. 1990; 267(2):467-70.

PMID: 2159284 PMC: 1131312. DOI: 10.1042/bj2670467.

References
1.
Denzlinger C, Guhlmann A, Scheuber P, Wilker D, Hammer D, Keppler D . Metabolism and analysis of cysteinyl leukotrienes in the monkey. J Biol Chem. 1986; 261(33):15601-6. View

2.
Hagmann W, Denzlinger C, Rapp S, Weckbecker G, Keppler D . Identification of the major endogenous leukotriene metabolite in the bile of rats as N-acetyl leukotriene E4. Prostaglandins. 1986; 31(2):239-51. DOI: 10.1016/0090-6980(86)90050-x. View

3.
McColl S, Hurst N, Cleland L . Modulation by phorbol myristate acetate of arachidonic acid release and leukotriene synthesis by human polymorphonuclear leukocytes stimulated with A23187. Biochem Biophys Res Commun. 1986; 141(2):399-404. DOI: 10.1016/s0006-291x(86)80186-3. View

4.
Dieter P, Altin J, Bygrave F . Possible involvement of prostaglandins in vasoconstriction induced by zymosan and arachidonic acid in the perfused rat liver. FEBS Lett. 1987; 213(1):174-8. DOI: 10.1016/0014-5793(87)81486-2. View

5.
Huber M, Guhlmann A, Jansen P, Keppler D . Hereditary defect of hepatobiliary cysteinyl leukotriene elimination in mutant rats with defective hepatic anion excretion. Hepatology. 1987; 7(2):224-8. DOI: 10.1002/hep.1840070204. View